Comparative analysis of peripheral and localised cytokine secretion in glioblastoma patients

Cytokine

Volumn 39, Issue 2, 2007, Pages 99-105

  Zisakis, Athanasios ^a   Piperi, Christina ^a   Themistocleous, Marios S ^b   Korkolopoulou, Penelope ^a   Boviatsis, Efstathios I ^b   Sakas, Damianos E ^b   Patsouris, Efstratios ^a   Lea, Robert W ^c   Kalofoutis, Anastasios ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b EVANGELISMOS HOSPITAL   (Greece)

^c UNIVERSITY OF CENTRAL LANCASHIRE   (United Kingdom)

Author keywords

Cytokine; Glioblastoma; Immunotherapy; Primary glioma cell line

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CANCER IMMUNOTHERAPY; CANCER PATIENT; CANCER SURVIVAL; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBIOLOGY; IMMUNOSURVEILLANCE; MALE; MALIGNANT NEOPLASTIC DISEASE; MONITORING; PERIPHERAL BLOOD MONONUCLEAR CELL; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; TH1 CELL; TH2 CELL;

ADULT; AGED; BRAIN NEOPLASMS; CELLS, CULTURED; CYTOKINES; FEMALE; GLIOBLASTOMA; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-1BETA; INTERLEUKIN-4; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34848812545     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2007.05.012     Document Type: Article

References (29)

1. Roth W., Weller M., Roth W., and Weller M. Chemotherapy and immunotherapy of malignant glioma: molecular mechanisms and clinical perspectives. Cell Mol Life Sci 56 5-6 (1999) 481-506
2. Hakyemez B., Erdogan C., Yildirim N., Parlak M., Hakyemez B., Erdogan C., et al. Glioblastoma multiforme with atypical diffusion-weighted MR findings. Br J Radiol 78 935 (2005) 989-992
3. Prados M.D., and Levin V. Biology and treatment of malignant glioma. Semin Oncol 27 (2000) 1-10
4. Hsieh J.C., and Lesniak M.S. Surgical management of high-grade gliomas. Expert Rev Neurother 5 (2005) S33-S39
5. Hussain S.F., and Heimberger A.B. Immunotherapy for human glioma: innovative approaches and recent results. Expert Rev Anticancer Ther 5 5 (2005) 777-790
6. Tjoa B.A., and Salgaller M.L. Progress in active-specific immunotherapy of brain malignancies. Expert Opin Investig Drugs 9 9 (2000) 2093-2101
7. Mitchell D.A., Fecci P.E., and Sampson J.H. Adoptive immunotherapy for malignant glioma. Cancer J 9 3 (2003) 157-166
8. De Vleeschouwer S., Van Gool S.W., and Van Calenbergh F. Immunotherapy for malignant gliomas: emphasis on strategies of active specific immunotherapy using autologous dendritic cells. Childs Nerv Syst 21 1 (2005) 7-18
9. Hao C., Parney I.F., Roa W.H., Turner J., Petruk K.C., Ramsay D.A., et al. Cytokine and cytokine receptor mRNA expression in human glioblastomas: evidence of Th1, Th2 and Th3 cytokine dysregulation. Acta Neuropathol (Berl) 103 2 (2002) 171-178
10. Noble M., Murray K., Stroobant P., Waterfield M.D., and Riddle P. Platelet-derived growth factor promotes division and motility and inhibits premature differentiation of the oligodendrocyte/type-2 astrocyte progenitor cell. Nature 333 (1988) 560-562
11. Saxena A., and Ali I.U. Increased expression of genes from growth factor signaling pathways in glioblastoma cell lines. Oncogene 7 (1992) 243-247
12. Szelengi J. Cytokines and the central nervous system. Brain Res Bull 54 (2001) 329-338
13. Goussia A.C., Agnantis N.J., Rao J.S., and Kyritsis A.P. Cytogenetic and molecular abnormalities in astrocytic gliomas. Oncol Rep 7 2 (2000) 401-412
14. Liu H., Jacobs B.S., Liu J., Prayson R.A., Estes M.L., Barnett G.H., et al. Interleukin-13 sensitivity and receptor phenotypes of human glial cell lines: non-neoplastic glia and low-grade astrocytoma differ from malignant glioma. Cancer Immunol Immunother 49 6 (2000) 319-324
15. Li V.W., Folkerth R.D., and Watanabe H. Microvessel count and cerebrospinal fluid basic fibroblast growth factor in children with brain tumours. Lancet 344 (1994) 82 6
16. Goswami S., Gupta A., and Sharma S.K. Interleukin-6-mediated autocrine growth promotion in human glioblastoma multiforme cell line U87MG. J Neurochem 71 (1998) 1837-1845
17. Nitta T., Ebato M., Sato K., and Okumura K. Expression of tumor necrosis factor-alpha, -beta and interferon-gamma genes within human neuroglial tumor cells and brain specimens. Cytokine 6 (1994) 171-180
18. Tada M., Diserens A.C., Desbaillets I., and de Tribolet N. Analysis of cytokine receptor messenger RNA expression in human glioblastoma cells and normal astrocytes by reverse-transcription polymerase chain reaction. J Neurosurg 80 (1994) 1063-1073
19. Bienvenu J., Moneret G., Fabien N., and Revillard J.P. The clinical usefulness of the measurement of cytokines. Clin Chem Lab Med 38 (2000) 267-285
20. Dix A.R., Brooks W.H., Roszman T.L., and Morford L.A. Immune defects observed in patients with primary malignant brain tumors. J Neuroimmunol 100 (1999) 216-232
21. Zou J.P., Morford L.A., Chougnet C., Dix A.R., Brooks A.G., Torres N., et al. Human glioma-induced immunosuppression involves soluble factor(s) that alters monocyte cytokine profile and surface markers. J Immunol 162 (1999) 4882-4892
22. Kito T., Kuroda E., Yokota A., and Yamashita U. Cytotoxicity in glioma cells due to interleukin-12 and interleukin-18-stimulated macrophages mediated by interferon-gamma-regulated nitric oxide. J Neurosurg 98 2 (2003) 385-392
23. Mosmann T.R., and Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 17 (1996) 138-146
24. Chung I.Y., and Benveniste E.N. Tumor necrosis factor-alpha production by astrocytes. Induction by lipopolysaccharide, IFN-gamma, and IL-1 beta. J Immunol 144 8 (1990) 2999-3007
25. Jiang Y., Woronicz J.D., Liu W., and Goeddel D.V. Prevention of constitutive TNF receptor 1 signaling by silencer of death domains. Science 283 (1999) 543-546
26. Cassatela M.A., Meda L., Bonora S., Ceska M., and Constantin G. Interleukin 10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1 beta in mediating the production of IL-8 triggered by lipopolysacharide. J Exp Med 178 (1993) 2207-2211
27. Chomarat P., Rissoan M.C., Banchereau J., and Miossec P. Interferon gamma inhibits interleukin 10 production by monocytes. J Exp Med 177 (1993) 523-527
28. Bogdan C., and Nathan C. Modulation of macrophage function by transforming growth factor beta, interleukin-4 and interleukin-10. Ann NY Acad Sci 685 (1993) 713-739
29. Kawakami M., Kawakami K., and Puri R. Interleukin-4-Pseudomonas exotoxin chimeric fusion protein for malignant glioma therapy. J Neuro-oncol 65 (2003) 15-25